Low	O
copy	O
numbers	O
of	O
FCGR3A	B:C1414555
and	O
FCGR3B	O
associated	O
with	O
Chinese	O
patients	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
.	O

Low	O
copy	O
numbers	O
of	O
FCGR3A	O
and	O
FCGR3B	B:C1414556
associated	O
with	O
Chinese	O
patients	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
.	O

Low	O
copy	O
numbers	O
of	O
FCGR3A	O
and	O
FCGR3B	O
associated	O
with	O
Chinese	B:C0152035
patients	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
.	O

Low	O
copy	O
numbers	O
of	O
FCGR3A	O
and	O
FCGR3B	O
associated	O
with	O
Chinese	O
patients	O
with	O
systemic	B:C0024143
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
.	O

Low	O
copy	O
numbers	O
of	O
FCGR3A	O
and	O
FCGR3B	O
associated	O
with	O
Chinese	O
patients	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	B:C2717865
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
.	O

Low	B:C0162826
-	I:C0162826
affinity	I:C0162826

Fcγ	I:C0162826
receptors	I:C0162826
(	O
Fcγ	B:C0162826
receptors	I:C0162826
)	O
act	O
as	O
key	O
mediators	O
of	O
the	O
pathogenic	O
effects	O
of	O
autoantibodies	O
.	O

Fcγ	I:C0162826
receptors	I:C0162826
(	O
Fcγ	O
receptors	I:C0162826
)	O
act	O
as	O
key	O
mediators	O
of	O
the	O
pathogenic	O
effects	O
of	O
autoantibodies	B:C0004358
.	O

In	O
this	O
study	B:C0008972
,	O
we	O
aimed	O
to	O
determine	O
whether	O
copy	O
number	I:C2717925
variations	I:C2717925
(	O
copy	O
number	I:C2717925
variations	I:C2717925
)	O
in	O
FCGR3A	O
and	O
FCGR3B	O
were	O
associated	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
(	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
)	O
and	O
ANCA	O
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
)	O
in	O
Chinese	O
individuals	I:C0152035
.	O

In	O
this	O
study	O
,	O
we	O
aimed	O
to	O
determine	O
whether	O
copy	B:C2717925
number	I:C2717925
variations	I:C2717925
(	O
copy	O
number	I:C2717925
variations	I:C2717925
)	O
in	O
FCGR3A	O
and	O
FCGR3B	O
were	O
associated	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
(	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
)	O
and	O
ANCA	O
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
)	O
in	O
Chinese	O
individuals	I:C0152035
.	O

In	O
this	O
study	O
,	O
we	O
aimed	O
to	O
determine	O
whether	O
copy	O
number	I:C2717925
variations	I:C2717925
(	O
copy	B:C2717925
number	I:C2717925
variations	I:C2717925
)	O
in	O
FCGR3A	O
and	O
FCGR3B	O
were	O
associated	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
(	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
)	O
and	O
ANCA	O
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
)	O
in	O
Chinese	O
individuals	I:C0152035
.	O

In	O
this	O
study	O
,	O
we	O
aimed	O
to	O
determine	O
whether	O
copy	O
number	I:C2717925
variations	I:C2717925
(	O
copy	O
number	I:C2717925
variations	I:C2717925
)	O
in	O
FCGR3A	B:C1414555
and	O
FCGR3B	O
were	O
associated	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
(	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
)	O
and	O
ANCA	O
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
)	O
in	O
Chinese	O
individuals	I:C0152035
.	O

In	O
this	O
study	O
,	O
we	O
aimed	O
to	O
determine	O
whether	O
copy	O
number	I:C2717925
variations	I:C2717925
(	O
copy	O
number	I:C2717925
variations	I:C2717925
)	O
in	O
FCGR3A	O
and	O
FCGR3B	B:C1414556
were	O
associated	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
(	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
)	O
and	O
ANCA	O
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
)	O
in	O
Chinese	O
individuals	I:C0152035
.	O

In	O
this	O
study	O
,	O
we	O
aimed	O
to	O
determine	O
whether	O
copy	O
number	I:C2717925
variations	I:C2717925
(	O
copy	O
number	I:C2717925
variations	I:C2717925
)	O
in	O
FCGR3A	O
and	O
FCGR3B	O
were	O
associated	O
with	O
systemic	B:C0024143
lupus	I:C0024143
nephritis	I:C0024143
(	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
)	O
and	O
ANCA	O
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
)	O
in	O
Chinese	O
individuals	I:C0152035
.	O

In	O
this	O
study	O
,	O
we	O
aimed	O
to	O
determine	O
whether	O
copy	O
number	I:C2717925
variations	I:C2717925
(	O
copy	O
number	I:C2717925
variations	I:C2717925
)	O
in	O
FCGR3A	O
and	O
FCGR3B	O
were	O
associated	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
(	O
systemic	B:C0024143
lupus	I:C0024143
nephritis	I:C0024143
)	O
and	O
ANCA	O
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
)	O
in	O
Chinese	O
individuals	I:C0152035
.	O

In	O
this	O
study	O
,	O
we	O
aimed	O
to	O
determine	O
whether	O
copy	O
number	I:C2717925
variations	I:C2717925
(	O
copy	O
number	I:C2717925
variations	I:C2717925
)	O
in	O
FCGR3A	O
and	O
FCGR3B	O
were	O
associated	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
(	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
)	O
and	O
ANCA	B:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
)	O
in	O
Chinese	O
individuals	I:C0152035
.	O

In	O
this	O
study	O
,	O
we	O
aimed	O
to	O
determine	O
whether	O
copy	O
number	I:C2717925
variations	I:C2717925
(	O
copy	O
number	I:C2717925
variations	I:C2717925
)	O
in	O
FCGR3A	O
and	O
FCGR3B	O
were	O
associated	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
(	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
)	O
and	O
ANCA	O
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
and	B:C2717865
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
)	O
in	O
Chinese	O
individuals	I:C0152035
.	O

In	O
this	O
study	O
,	O
we	O
aimed	O
to	O
determine	O
whether	O
copy	O
number	I:C2717925
variations	I:C2717925
(	O
copy	O
number	I:C2717925
variations	I:C2717925
)	O
in	O
FCGR3A	O
and	O
FCGR3B	O
were	O
associated	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
(	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
)	O
and	O
ANCA	O
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
)	O
in	O
Chinese	B:C0152035
individuals	I:C0152035
.	O

A	O
total	O
of	O
1118	O
individuals	B:C0027361
were	O
enrolled	O
,	O
including	O
415	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
patients	O
,	O
139	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
patients	O
,	O
and	O
564	O
healthy	O
controls	O
.	O

A	O
total	O
of	O
1118	O
individuals	O
were	O
enrolled	B:C1516879
,	O
including	O
415	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
patients	O
,	O
139	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
patients	O
,	O
and	O
564	O
healthy	O
controls	O
.	O

A	O
total	O
of	O
1118	O
individuals	O
were	O
enrolled	O
,	O
including	O
415	O
systemic	B:C0024143
lupus	I:C0024143
nephritis	I:C0024143
patients	O
,	O
139	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
patients	O
,	O
and	O
564	O
healthy	O
controls	O
.	O

A	O
total	O
of	O
1118	O
individuals	O
were	O
enrolled	O
,	O
including	O
415	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
patients	O
,	O
139	O
and	B:C2717865
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
patients	O
,	O
and	O
564	O
healthy	O
controls	O
.	O

FCGR3A	B:C1414555
and	O
FCGR3B	O
copy	O
numbers	O
(	O
CNs	O
)	O
were	O
determined	O
by	O
both	O
a	O
paralogue	O
ratio	I:C0022885
test	I:C0022885
and	O
TaqMan	O
quantitative	I:C0200931
PCR	I:C0200931
assay	I:C0200931
.	O

FCGR3A	O
and	O
FCGR3B	B:C1414556
copy	O
numbers	O
(	O
CNs	O
)	O
were	O
determined	O
by	O
both	O
a	O
paralogue	O
ratio	I:C0022885
test	I:C0022885
and	O
TaqMan	O
quantitative	I:C0200931
PCR	I:C0200931
assay	I:C0200931
.	O

FCGR3A	O
and	O
FCGR3B	O
copy	O
numbers	O
(	O
CNs	O
)	O
were	O
determined	O
by	O
both	O
a	O
paralogue	B:C0022885
ratio	I:C0022885
test	I:C0022885
and	O
TaqMan	O
quantitative	I:C0200931
PCR	I:C0200931
assay	I:C0200931
.	O

FCGR3A	O
and	O
FCGR3B	O
copy	O
numbers	O
(	O
CNs	O
)	O
were	O
determined	O
by	O
both	O
a	O
paralogue	O
ratio	I:C0022885
test	I:C0022885
and	O
TaqMan	B:C0200931
quantitative	I:C0200931
PCR	I:C0200931
assay	I:C0200931
.	O

In	O
the	O
susceptibility	B:C0012655
associations	O
,	O
a	O
low	O
FCGR3B	O
CN	O
was	O
significantly	O
associated	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
(	O
p	O
=	O
5.01	O
×	O
10	O
(	O
-	O
3	O
)	O
;	O
odds	O
ratio	O
(	O
OR	O
)	O
1.71	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
1.17	O
-	O
2.48	O
)	O
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
p	O
=	O
0.04	O
;	O
OR	O
=	O
1.72	O
;	O
95	O
%	O
CI	O
1.02	O
-	O
2.88	O
)	O
.	O

In	O
the	O
susceptibility	O
associations	O
,	O
a	O
low	O
FCGR3B	B:C1414556
CN	O
was	O
significantly	O
associated	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
(	O
p	O
=	O
5.01	O
×	O
10	O
(	O
-	O
3	O
)	O
;	O
odds	O
ratio	O
(	O
OR	O
)	O
1.71	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
1.17	O
-	O
2.48	O
)	O
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
p	O
=	O
0.04	O
;	O
OR	O
=	O
1.72	O
;	O
95	O
%	O
CI	O
1.02	O
-	O
2.88	O
)	O
.	O

In	O
the	O
susceptibility	O
associations	O
,	O
a	O
low	O
FCGR3B	O
CN	O
was	O
significantly	O
associated	O
with	O
systemic	B:C0024143
lupus	I:C0024143
nephritis	I:C0024143
(	O
p	O
=	O
5.01	O
×	O
10	O
(	O
-	O
3	O
)	O
;	O
odds	O
ratio	O
(	O
OR	O
)	O
1.71	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
1.17	O
-	O
2.48	O
)	O
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
p	O
=	O
0.04	O
;	O
OR	O
=	O
1.72	O
;	O
95	O
%	O
CI	O
1.02	O
-	O
2.88	O
)	O
.	O

In	O
the	O
susceptibility	O
associations	O
,	O
a	O
low	O
FCGR3B	O
CN	O
was	O
significantly	O
associated	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
(	O
p	O
=	O
5.01	O
×	O
10	O
(	O
-	O
3	O
)	O
;	O
odds	O
ratio	O
(	O
OR	O
)	O
1.71	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
1.17	O
-	O
2.48	O
)	O
and	O
and	B:C2717865
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
p	O
=	O
0.04	O
;	O
OR	O
=	O
1.72	O
;	O
95	O
%	O
CI	O
1.02	O
-	O
2.88	O
)	O
.	O

A	O
low	O
FCGR3A	B:C1414555
CN	O
was	O
also	O
significantly	O
associated	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
(	O
p	O
=	O
6.02	O
×	O
10	O
(	O
-3	O
)	O
;	O
OR	O
2.72	O
;	O
95	O
%	O
CI	O
1.30	O
-	O
5.71	O
)	O
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
p	O
=	O
0.042	O
;	O
OR	O
2.64	O
;	O
95	O
%	O
CI	O
1.00	O
-	O
6.93	O
)	O
.	O

A	O
low	O
FCGR3A	O
CN	O
was	O
also	O
significantly	O
associated	O
with	O
systemic	B:C0024143
lupus	I:C0024143
nephritis	I:C0024143
(	O
p	O
=	O
6.02	O
×	O
10	O
(	O
-3	O
)	O
;	O
OR	O
2.72	O
;	O
95	O
%	O
CI	O
1.30	O
-	O
5.71	O
)	O
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
p	O
=	O
0.042	O
;	O
OR	O
2.64	O
;	O
95	O
%	O
CI	O
1.00	O
-	O
6.93	O
)	O
.	O

A	O
low	O
FCGR3A	O
CN	O
was	O
also	O
significantly	O
associated	O
with	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
(	O
p	O
=	O
6.02	O
×	O
10	O
(	O
-3	O
)	O
;	O
OR	O
2.72	O
;	O
95	O
%	O
CI	O
1.30	O
-	O
5.71	O
)	O
and	O
and	B:C2717865
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
(	O
p	O
=	O
0.042	O
;	O
OR	O
2.64	O
;	O
95	O
%	O
CI	O
1.00	O
-	O
6.93	O
)	O
.	O

Further	O
subphenotype	O
analysis	B:C0936012
revealed	O
that	O
low	O
CNs	O
of	O
FCGR3A	O
and	O
FCGR3B	O
were	O
significantly	O
associated	O
with	O
clinical	O
manifestations	O
in	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
patients	O
.	O

Further	O
subphenotype	O
analysis	O
revealed	O
that	O
low	O
CNs	O
of	O
FCGR3A	B:C1414555
and	O
FCGR3B	O
were	O
significantly	O
associated	O
with	O
clinical	O
manifestations	O
in	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
patients	O
.	O

Further	O
subphenotype	O
analysis	O
revealed	O
that	O
low	O
CNs	O
of	O
FCGR3A	O
and	O
FCGR3B	B:C1414556
were	O
significantly	O
associated	O
with	O
clinical	O
manifestations	O
in	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
patients	O
.	O

Further	O
subphenotype	O
analysis	O
revealed	O
that	O
low	O
CNs	O
of	O
FCGR3A	O
and	O
FCGR3B	O
were	O
significantly	O
associated	O
with	O
clinical	O
manifestations	O
in	O
systemic	B:C0024143
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
patients	O
.	O

Further	O
subphenotype	O
analysis	O
revealed	O
that	O
low	O
CNs	O
of	O
FCGR3A	O
and	O
FCGR3B	O
were	O
significantly	O
associated	O
with	O
clinical	O
manifestations	O
in	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	B:C2717865
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
patients	O
.	O

Therefore	O
,	O
in	O
this	O
case	B:C0007328
-	I:C0007328
control	I:C0007328
study	I:C0007328
,	O
we	O
identified	O
low	O
CNs	O
of	O
FCGR2A	O
and	O
FCGR3B	O
to	O
be	O
common	O
risk	O
factors	I:C0035648
for	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
.	O

Therefore	O
,	O
in	O
this	O
case	O
-	I:C0007328
control	I:C0007328
study	I:C0007328
,	O
we	O
identified	O
low	O
CNs	O
of	O
FCGR2A	B:C1414553
and	O
FCGR3B	O
to	O
be	O
common	O
risk	O
factors	I:C0035648
for	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
.	O

Therefore	O
,	O
in	O
this	O
case	O
-	I:C0007328
control	I:C0007328
study	I:C0007328
,	O
we	O
identified	O
low	O
CNs	O
of	O
FCGR2A	O
and	O
FCGR3B	B:C1414556
to	O
be	O
common	O
risk	O
factors	I:C0035648
for	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
.	O

Therefore	O
,	O
in	O
this	O
case	O
-	I:C0007328
control	I:C0007328
study	I:C0007328
,	O
we	O
identified	O
low	O
CNs	O
of	O
FCGR2A	O
and	O
FCGR3B	O
to	O
be	O
common	O
risk	B:C0035648
factors	I:C0035648
for	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
.	O

Therefore	O
,	O
in	O
this	O
case	O
-	I:C0007328
control	I:C0007328
study	I:C0007328
,	O
we	O
identified	O
low	O
CNs	O
of	O
FCGR2A	O
and	O
FCGR3B	O
to	O
be	O
common	O
risk	O
factors	I:C0035648
for	O
systemic	B:C0024143
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	O
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
.	O

Therefore	O
,	O
in	O
this	O
case	O
-	I:C0007328
control	I:C0007328
study	I:C0007328
,	O
we	O
identified	O
low	O
CNs	O
of	O
FCGR2A	O
and	O
FCGR3B	O
to	O
be	O
common	O
risk	O
factors	I:C0035648
for	O
systemic	O
lupus	I:C0024143
nephritis	I:C0024143
and	O
and	B:C2717865
ANCA	I:C2717865
-	I:C2717865
associated	I:C2717865
systemic	I:C2717865
vasculitis	I:C2717865
.	O

